Decreased CD11c‐positive dendritic cells in the tumor microenvironment predict double‐hit/triple‐hit genotype and survival in diffuse large B‐cell lymphoma
Abstract Diffuse large B‐cell lymphoma (DLBCL) is the most common type of non‐Hodgkin lymphoma and is a potentially curable disease. However, it is heterogenous, and the prognosis is poor if the tumor cells harbor fusions involving MYC and BCL2 or MYC and BCL6 (double‐hit [DH] lymphoma), or fusions...
Main Authors: | Chang‐Tsu Yuan, Shih‐Sung Chuang, Pei‐Yuan Cheng, Koping Chang, Hsuan Wang, Jia‐Huei Tsai, Jau‐Yu Liau, Wen‐Chien Chou |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-09-01
|
Series: | The Journal of Pathology: Clinical Research |
Subjects: | |
Online Access: | https://doi.org/10.1002/cjp2.283 |
Similar Items
-
Copy Number Alteration and Mutational Profile of High-Grade B-Cell Lymphoma with <i>MYC</i> and <i>BCL2</i> and/or <i>BCL6</i> Rearrangements, Diffuse Large B-Cell Lymphoma with <i>MYC</i>-Rearrangement, and Diffuse Large B-Cell Lymphoma with <i>MYC</i>-Cluster Amplification
by: Masashi Miyaoka, et al.
Published: (2022-11-01) -
Clinical and Pathological Features of Double-Hit and Triple-Hit High-Grade B-Cell Lymphomas: A Retrospective Study from Three Portuguese Tertiary Centers
by: Rui Almeida, et al.
Published: (2022-04-01) -
Drug therapy for double-hit lymphoma
by: Vania Phuoc, et al.
Published: (2019-12-01) -
High-Grade B-Cell Lymphoma (HGBL) with <i>MYC</i> and <i>BCL2</i> and/or <i>BCL6</i> Rearrangements Is Predominantly BCL6-Rearranged and BCL6-Expressing in Taiwan
by: Cheng-Chih Tsai, et al.
Published: (2021-03-01) -
Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors
by: Weiping Li, et al.
Published: (2019-07-01)